Skip to main content
. 2011 May 24;19(10):1813–1820. doi: 10.1038/mt.2011.92

Figure 4.

Figure 4

MVPNPCDVenvantiCEA synergizes with fludarabine in an animal model. Subcutaneous MC38CEA tumors were established in C57BL/6 mice with one million cells. Mice received four consecutive intravenous injections of MVPNPCDVenvantiCEA (triangles), MVPNPantiCEA (diamonds), or mock (squares), followed by 3 consecutive days of intraperitoneal injection of 250 mg/kg of fludarabine (F-araAMP). Control mice received neither virus nor F-araAMP (circles). (a) Left, average tumor volume over time; right, tumor volume for all mice on day 14. (b) Survival curves. The defined endpoint was 1,500 µl tumor volume. CDV, canine distemper virus; CEA, carcinoembryonic antigen; MV, measles virus; PNP, purine nucleoside phosphorylase.